Letters to the Editor

Five-year outcomes of CD19 followed by CD22 chimeric antigen receptor T-cell therapy in B-cell acute lymphoblastic leukemia patients who relapsed after allo-transplantation

Department of Hematology, Beijing Gobroad Boren Hospital, Beijing
Department of Hematology, Beijing Gobroad Boren Hospital, Beijing
Department of Hematology, Beijing Gobroad Boren Hospital, Beijing
Department of Hematology, Beijing Gobroad Boren Hospital, Beijing
Department of Hematology, Beijing Gobroad Boren Hospital, Beijing
Cytology Laboratory, Beijing Gobroad Boren Hospital, Beijing
Medical Laboratory, Beijing Gobroad Boren Hospital, Beijing
Medical Laboratory, Beijing Gobroad Boren Hospital, Beijing
Department of Hematology, Beijing Gobroad Boren Hospital, Beijing
Department of Bone Marrow Transplantation, Beijing Gobroad Boren Hospital, Beijing
Shanghai YaKe Biotechnology Ltd., Shanghai
Department of Hematology, Beijing Gobroad Boren Hospital, Beijing
Haematologica Early view Dec 12, 2024 https://doi.org/10.3324/haematol.2024.286534